A Phase IV Study to Evaluate the Immunogenicity and Safety in UK Laboratory Workers of Menitorix

NCT00503165 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Vaccination

Interventions

BIOLOGICAL: Menitorix (MenC and Hib conjugate)

Sponsor

Public Health England